Nogest (Nomegestrol Acetate)

Nomegestrol acetate binds selectively to progesterone receptors, inhibiting the luteinizing hormone surge and thereby suppressing ovulation. In the uterus, it induces a secretory endometrium that counteracts estrogen‑driven proliferation, supporting contraceptive and replacement therapy goals.

The specific dose and regimen of Nogest are determined by the prescribing healthcare professional based on the patient’s clinical situation, regulatory guidelines, and therapeutic objectives. Patients should follow the prescriber’s instructions exactly.

Nogest is contraindicated during pregnancy because it can affect fetal development. Its safety during breastfeeding has not been established; therefore, use is generally avoided unless the benefits to the mother clearly outweigh potential risks to the infant.

To request Nogest, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with older progestogens, nomegestrol acetate offers a high receptor selectivity, which may result in a more favorable bleeding profile and lower androgenic activity. However, efficacy and safety are comparable, and the choice depends on individual patient factors and clinician preference.

Nogest tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and keep out of reach of children.

Nogest is taken orally, usually once daily at the same time each day, as directed by the prescriber. Swallow the tablet whole with water; do not crush or chew unless specifically instructed.

The most serious risks include venous thromboembolism, hepatic dysfunction, and severe allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as unexplained leg swelling, jaundice, or signs of anaphylaxis.

Nogest should not be used by women with a history of thromboembolic disorders, severe liver disease, uncontrolled hypertension, known hypersensitivity to nomegestrol acetate, or those who are currently pregnant. A thorough medical assessment is essential before initiating therapy.